These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38031224)

  • 1. COVID-19 vaccine safety and side effects in children aged 5-11 years: a cross-sectional study.
    Nurhani MA; Farah HMS; Ili NMA; Zahidah AR; Rahimah B; Nabilah HK; Gan LL; David NCE
    Med J Malaysia; 2023 Nov; 78(6):803-807. PubMed ID: 38031224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
    Malden DE; Gee J; Glenn S; Li Z; Mercado C; Ogun OA; Kim S; Lewin BJ; Ackerson BK; Jazwa A; Weintraub ES; McNeil MM; Tartof SY
    Vaccine; 2023 Jan; 41(2):315-322. PubMed ID: 36351861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia.
    Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE
    Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
    Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
    Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey.
    Shapiro Ben David S; Baruch Gez S; Adler L; Kovatch R; Rahamim-Cohen D; Shamir-Stein N; Shahar A; Mizrhi-Reuveni M
    Vaccine; 2024 Feb; 42(5):1154-1159. PubMed ID: 38281902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, effectiveness and hesitancy of COVID-19 vaccination in children: A cross-sectional study in Pakistan.
    Zaufishan Z; Usman M; Fishan Mumtaz K; Bilal R; Arshad A; Khan HM
    Front Public Health; 2022; 10():1084017. PubMed ID: 36733278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study.
    Najjar M; Albuaini S; Fadel M; Mohsen F; ; Najjar G; Assaf D; Aljbawi A; AlAwad Y
    Ann Med; 2023; 55(2):2241351. PubMed ID: 37544017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
    Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
    BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
    Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A;
    JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
    Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluate the side effect associated with COVID-19 vaccine on adolescents in Riyadh, Saudi Arabia: A cross-section study.
    Aldali JA; Alotaibi FT; Alasiri GA; Almesned RA; Alromih AM; Almohandes AM; Alsenidi SF
    Saudi Med J; 2022 Nov; 43(11):1248-1253. PubMed ID: 36379531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis.
    Matson RP; Niesen MJM; Levy ER; Opp DN; Lenehan PJ; Donadio G; O'Horo JC; Venkatakrishnan AJ; Badley AD; Soundararajan V
    Lancet Digit Health; 2023 Apr; 5(4):e206-e216. PubMed ID: 36963910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey.
    Vatcharavongvan P; Boonyanitchayakul N; Khampachuea P; Sinturong I; Prasert V
    Vaccine; 2023 Feb; 41(8):1480-1489. PubMed ID: 36707336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.